Quipt Home Medical Corp.

NASDAQ•QIPT

執行長: Mr. Gregory J. Crawford

板塊: Healthcare

行業: Medical - Devices

上市日期: 2010-08-10

Quipt Home Medical Corp., through its subsidiaries, engages in the provision of durable and home medical equipment and supplies in the United States. The company offers nebulizers, oxygen concentrators, and CPAP and BiPAP units; traditional and non-traditional durable medical respiratory equipment and services; non-invasive ventilation equipment, supplies, and services; and engages in the rental of medical equipment. It offers management of various chronic disease states focusing on patients with heart and pulmonary disease, sleep apnea, reduced mobility, and other chronic health conditions. The company was formerly known as Protech Home Medical Corp. and changed its name to Quipt Home Medical Corp. in May 2021. Quipt Home Medical Corp. is headquartered in Wilder, Kentucky.

聯絡資訊

1019 Town Drive, Wilder, KY, 41076, United States

859-878-2220

quipthomemedical.com

市值

$161.85M

本益比 (TTM)

-14.3

股息率

52周最高

$3.65

52周最低

$1.35

52周範圍

100%

排名50Top 68.9%

3.1

F-Score

改良版 Piotroski 分析

基於 10 年期基本面

疲弱 • 3.1 / 9 分

評分區間 (0-9)

8-9: 價值優異

6-7: 基本面強勁

4-5: 整體穩健

0-3: 表現疲弱

資料區間: 2016-2025

財務儀表板

Q1 2026 數據

營業收入

$111.17M+0.00%

近4季度走勢

每股收益

-$0.03+0.00%

近4季度走勢

自由現金流

$6.97M+0.00%

近4季度走勢

2026 Q1 財報亮點

核心亮點

Revenue Growth Strong Total revenue reached $81.0M USD for the quarter, marking a 32% increase from $61.4M USD last year, driven by recent acquisitions.

Operating Income Improvement Operating income rose substantially to $1.02M USD compared to $448K USD in the prior year period, showing improved core profitability.

Net Loss Slightly Reduced Quarterly net loss decreased marginally to $1.05M USD versus $1.08M USD reported previously, resulting in better basic loss per share.

Stable Operating Cash Flow Net cash flow provided by operating activities was $8.94M USD, remaining relatively flat compared to $9.30M USD last year.

關注風險

Arrangement Closing Uncertainty Consummation of the acquisition agreement is subject to shareholder vote and regulatory approvals; failure could negatively impact share price.

DOJ Investigation Ongoing Company faces a civil investigative demand from the DOJ regarding CPAP equipment claims, posing an uncertain material adverse risk.

Increased Stock Compensation Stock-based compensation expense increased sharply to $982K USD from $207K USD, reflecting new long-term incentive grants.

Operating Restrictions Pending The Arrangement Agreement imposes covenants restricting strategic initiatives until closing, potentially delaying response to market changes.

未來展望

Future Growth Priorities Set Priorities focus on driving organic revenue growth, achieving operational net profit, and expanding Adjusted EBITDA beyond current fiscal year.

Post-Acquisition Integration Focus Management is optimizing organizational structure and centralizing back-office processes to support scalable long-term growth following recent deals.

Sufficient Liquidity Expected Current cash on hand of $10.54M USD and credit availability are expected to fund operations for the next twelve months.

Debt Repayment Schedule The $110.0M USD senior credit facility has $84.0M USD outstanding, with scheduled principal repayments commencing in 2026.

同行對比

營業收入 (TTM)

DCGO

$368.09M

-47.0%

QIPT

$315.49M

+31.9%

MGNX

$149.50M

+0.8%

毛利率 (最新季度)

RCEL

81.2%

-2.4pp

QIPT

71.4%

+104.6pp

XTNT

66.1%

+7.8pp

關鍵指標

股票代碼	市值	本益比 (TTM)	股東權益報酬率 (TTM)	負債率
PRE	$280.23M	-5.5	-36.0%	1.1%
MGNX	$216.98M	-2.9	-120.2%	14.3%
ANIK	$208.53M	-19.0	-7.4%	12.7%

長期趨勢

近4季度

營業收入

淨利

營運現金流

4季度營業收入複合增長率

24.7%

高速增長

4季度淨利複合增長率

N/M

盈利狀態轉變

現金流穩定性

100%

現金流表現優異

深度研究

下次財報:2026年5月11日

每股收益:-

營業收入:$104.35M

財務數據

電話會議

財務報告

新聞

損益表

資產負債表

現金流量表

財務比率

變化率

損益表	過去12個月

無資料